To explore the biological mechanisms associated with XPO1 overexpression in gliomas, DEGs were identified by comparing the mRNA expression profiles between the RR_XPO1_high and RS_XPO1_low groups. This evidence concerns the gene XPO1 and central nervous system cancer.